CANDRIAM S.C.A. – Chinook Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$17.12M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+12.41%
quarter
Chinook Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.89M | $19.66 | 871.15K | |
| Q2 2022 | share | Decrease | -26.50% | -314.15K shares | -4.15M | $17.49 | 871.15K |
| Q1 2022 | share | Increase | +7.28% | 80.41K shares | 1.37M | $16.36 | 1.18M |
| Q4 2021 | share | Increase | +22.42% | 202.36K shares | 6.50M | $16.14 | 1.10M |
| Q3 2021 | share | Increase | +3.13% | 27.41K shares | -841K | $12.76 | 902.53K |
| Q2 2021 | share | Increase | 0.00% | 875.12K shares | 12.35M | $14.12 | 875.12K |